Compound Detail
CHEMBL541700
GALLINAMIDE A Enter ChEMBL ID:
Free Research Context
This compound will appear in recent viewed items on the research home for this browser.
Research home
View demo workspace
CC[C@H](C)[C@@H](C(=O)O[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)/C=C/C(=O)N1C(=O)C=C(OC)[C@@H]1C)N(C)C
Basic Information
| ChEMBL ID | CHEMBL541700 |
| Name | GALLINAMIDE A |
| Phase | Preclinical |
| Structure Type | MOL |
| InChI Key | ASRBKZHDORPEHO-KYJIWOQOSA-N |
20
Targets
34
Activities
3
Assay Types
0
PK Parameters
20
Publications
0
Known Names
Molecular Properties
592.8
MW (Da)
2.80
ALogP
8
HBA
2
HBD
134.3
PSA (Ų)
0.21
QED
1
Ro5 Violations
16
Rot. Bonds
Drug Information
| Molecule Type | Small molecule |
| Availability | Unknown |
| Chirality | Unknown |
Activity Summary
IC50 30 meas. best 9.59
Ki 3 meas. best 8.28
EC50 1 meas. best 7.55
Target Activity Profile
| Target | Type | Best pChEMBL | Mean pChEMBL | Best (nM) | # Data |
|---|---|---|---|---|---|
| Cruzipain CHEMBL3563 | IC50 | 9.59 | 9.24 | 0.3 | 2 |
| Procathepsin L CHEMBL3837 | IC50 | 8.33 | 8.065 | 4.7 | 4 |
| Procathepsin L CHEMBL5291 | Ki | 8.28 | 8.28 | 5.3 | 1 |
| Cathepsin B CHEMBL4072 | IC50 | 8.13 | 6.4267 | 7.3 | 3 |
| Procathepsin L CHEMBL3837 | Ki | 8.1 | 8.1 | 8.0 | 1 |
| Falcipain 2 CHEMBL5800 | IC50 | 8.07 | 8.07 | 8.5 | 3 |
| Falcipain-3 CHEMBL1250373 | IC50 | 7.66 | 7.66 | 22.0 | 1 |
| Unchecked CHEMBL612545 | IC50 | 7.66 | 7.255 | 22.0 | 2 |
| SARS-CoV-2 CHEMBL4303835 | EC50 | 7.55 | 7.55 | 28.0 | 1 |
| Plasmodium falciparum CHEMBL364 | IC50 | 7.3 | 6.56 | 50.0 | 3 |
| Cathepsin B CHEMBL4072 | Ki | 6.93 | 6.93 | 117.0 | 1 |
| Cathepsin L2 CHEMBL3272 | IC50 | 6.85 | 6.595 | 140.0 | 2 |
| Leishmania donovani CHEMBL367 | IC50 | 5.03 | 5.03 | 9300.0 | 1 |
| HeLa CHEMBL399 | IC50 | 4.92 | 4.92 | 12000.0 | 1 |
| PANC-1 CHEMBL614139 | IC50 | 4.51 | 4.51 | 31200.0 | 1 |
| MDA-MB-231 CHEMBL400 | IC50 | 4.46 | 4.46 | 34900.0 | 1 |
| 4T1 CHEMBL612589 | IC50 | 4.46 | 4.46 | 34600.0 | 1 |
| A549 CHEMBL392 | IC50 | 4.39 | 4.39 | 40400.0 | 1 |
| MCF7 CHEMBL387 | IC50 | 4.34 | 4.34 | 45500.0 | 1 |
| A-375 CHEMBL613859 | IC50 | 4.34 | 4.34 | 45600.0 | 1 |
| HT-29 CHEMBL384 | IC50 | 4.28 | 4.28 | 53000.0 | 1 |
| B16-F10 CHEMBL612656 | IC50 | 4.22 | 4.22 | 59700.0 | 1 |
Activity Data Samples
Top measurements by pChEMBL value
Literature References
| PubMed | DOI | Target Context | # Activities |
|---|---|---|---|
| 34730959 | 10.1021/acs.jmedchem.1c01494 | SARS-CoV-2 | 10 |
| 34730959 | 10.1021/acs.jmedchem.1c01494 | Procathepsin L | 9 |
| 34730959 | 10.1021/acs.jmedchem.1c01494 | Cathepsin B | 8 |
| 24364476 | 10.1021/np400727r | Procathepsin L | 7 |
| 31539239 | 10.1021/acs.jmedchem.9b00294 | Procathepsin L | 5 |
| 24364476 | 10.1021/np400727r | Unchecked | 4 |
| 24364476 | 10.1021/np400727r | Cathepsin L2 | 2 |
| 25412465 | 10.1021/jm501439w | Falcipain 2 | 2 |
| 25412465 | 10.1021/jm501439w | Unchecked | 2 |
| 34730959 | 10.1021/acs.jmedchem.1c01494 | Replicase polyprotein 1ab | 2 |
| 24364476 | 10.1021/np400727r | Cathepsin B | 2 |
| 24364476 | 10.1021/np400727r | Pro-cathepsin H | 2 |
| 19161344 | 10.1021/np8003529 | Trypanosoma cruzi | 1 |
| 25412465 | 10.1021/jm501439w | Plasmodium falciparum | 1 |
| 30006166 | 10.1016/j.ejmech.2018.06.046 | 4T1 | 1 |
| 37229831 | 10.1016/j.ejmech.2023.115503 | SARS-CoV-2 | 1 |
| 19161344 | 10.1021/np8003529 | Leishmania donovani | 1 |
| 30006166 | 10.1016/j.ejmech.2018.06.046 | HT-29 | 1 |
| 30006166 | 10.1016/j.ejmech.2018.06.046 | A-375 | 1 |
| 19161344 | 10.1021/np8003529 | Plasmodium falciparum | 1 |
Data from ChEMBL 36 via Core Engine